
Matej Mikulic
Research expert covering health, pharma & medtech
Bayer AG remains one of Europe’s leading life sciences companies, operating across pharmaceuticals, consumer health, and crop science. In 2025, the German group generated around 46 billion euros in sales while employing close to 89,000 people globally. Its business model is notably diversified, with pharmaceuticals contributing roughly two-fifths of total revenue, complemented by strong positions in agriculture and a resilient consumer health unit. Within pharma, blockbuster drugs such as Eylea continue to anchor performance. At the same time, Bayer operates in a highly competitive global pharmaceutical market valued at around 1.7 trillion U.S. dollars, where scale and innovation remain decisive factors.

Detailed statistics
Bayer Group sales 1995-2025

Detailed statistics
Bayer Group net income 1995-2025

Detailed statistics
Bayer Group number of employees 2009-2025

Pharmaceutical market size worldwide 2001-2029
Market size of the worldwide pharmaceutical industry from 2001 to 2024, with estimates for 2029 (in billion U.S. dollars)

Major 50 pharmaceutical companies - Rx sales and R&D spending 2024
Leading 50 global pharmaceutical companies by prescription sales and R&D spending in 2024 (in billion U.S. dollars)

World's most valuable pharmaceutical brands 2025 by brand value
Most valuable pharmaceutical brands worldwide as of 2025 (in billion U.S. dollars)

Pharma company ranking based on access to medicine in developing countries 2024
Overall pharmaceutical company ranking of the Access to Medicine Index for developing countries as of 2024

2025 global list of leading chemical companies based on revenue
2025 ranking of the global leading chemical companies based on revenue (in billion U.S. dollars)

AI readiness of big pharma companies 2025
Index of AI readiness of select big pharma companies as of 2025

Bayer Group's operating numbers 2007-2025
Sales, EBIT, and net income of Bayer Group from 2007 to 2025 (in billion euros)

Bayer Group sales 1995-2025
Total sales of Bayer Group from 1995 to 2025 (in million euros)

Bayer Group net income 1995-2025
Net income of Bayer Group from 1995 to 2025 (in million euros)

Bayer Group's total assets 2009-2025
Total assets of Bayer Group from 2009 to 2025 (in million euros)

Bayer Group number of employees 2009-2025
Employees of Bayer Group from 2009 to 2025

Distribution of Bayer Group net sales 2022-2025, by segment
Distribution of Bayer Group's net sales from 2022 to 2025, by segment

Bayer AG major pharmaceutical products based on revenue 2023-2025
Leading pharmaceutical products of Bayer AG from 2023 to 2025, based on revenue (in million euros)

Bayer Consumer Health net sales 2018-2025
Net sales of Bayer Consumer Health from 2018 to 2025 (in million euros)

Bayer CropScience revenue 2005-2025
Revenue of Bayer CropScience from 2005 to 2025 (in million euros)

Johnson & Johnson revenue 2005-2025
Revenue of Johnson & Johnson from 2005 to 2025 (in million U.S. dollars)

Pfizer revenue 2006-2025
Revenue of Pfizer from 2006 to 2025 (in million U.S. dollars)

Novartis' revenue 2007-2025
Novartis AG's total revenue from 2007 to 2025 (in billion U.S. dollars)

Syngenta AG's sales worldwide 2013-2025
Sales of Syngenta AG worldwide from 2013 to 2025 (in billion U.S. dollars)

Corteva Agriscience's revenue 2018-2025
Revenue of Corteva Agriscience from 2018 to 2025 (in million U.S. dollars)

BASF's annual revenue 2000-2025
Annual revenue of BASF from 2000 to 2025 (in million euros)

Glyphosate-related penalty payments made by Bayer in the US 2018-2026
Bayer's estimated glyphosate-related penalty payments in the U.S. between 2018 and 2026 (in million U.S. dollars)

Monsanto's net sales 2008-2017
Monsanto's net sales from 2008 to 2017 (in million U.S. dollars)*

Monsanto's total assets 2008-2017
Monsanto's total assets worldwide from 2008 to 2017 (in million U.S. dollars)*

Bayer and Monsanto merger - selected data 2016
Selected data in relation to the pending Bayer and Monsanto merger as of 2016

Bayer's acquisition offers to Monsanto May-September 2016
Value of acquisition offers from Bayer's takeover of Monsanto between May and September 2016 (in U.S. dollars per share)
Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.